Massuti, B., Nadal, E., Gonzalez-Larriba, J., Martinez-Marti, A., Bernabé, R., Bosch-Barrera, J., Lázaro, M., Calvo, V., Insa, A., Aix, S. P., Reguart, N., Castro, J. D., Campelo, R. G., Camps, C., Cobo, M., Viteri, S., Azkona, E., Pereira, E., Provencio, M. (2025). Pharmacoeconomic analysis of perioperative chemo-immunotherapy in resectable stage III non small cell lung cancer (NSCLC): Survival time cost-efficacy based on NADIM 2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e23141